3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Surveys and Questionnaires
58
Blood Specimen Collection
31
Surgical Procedures, Operative
13
Interviews as Topic
13
Immunohistochemistry
13
Data Collection
13
niraparib
12
Hyperthermic Intraperitoneal Chemotherapy
11
Observation
10
Drug Therapy
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
Radiotherapy
8
Polymerase Chain Reaction
8
Papanicolaou Test
8
Colposcopy
8
Cisplatin
8
Biopsy
8
Amplified Fragment Length Polymorphism Analysis
8
olaparib
7
Carboplatin
7
Ultrasonography
6
Sentinel Lymph Node Biopsy
6
Psychiatric Rehabilitation
6
Paclitaxel
6
Microarray Analysis
6
Laparoscopy
6
Hysterectomy
6
DNA Methylation
6
liposomal doxorubicin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Blood Component Removal
×
Gynecologic
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled